Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.09 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.09 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |